Skip to main content

Table 1 EPIC cohort characteristics for all women and postmenopausal women at baseline recruitment, 2010.

From: Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study

 

All women

Postmenopausal women

BMI tertiles6

   

1

2

3

 

( n = 314760)

(n = 144223)

( n = 36792)

( n = 48846)

( n = 58585)

Person years

3399178

1542924

391812

525727

625386

Age at recruitment 1

50.9(19.9-98.5)

58.1(27.8-98.5)

56.8(32.4-98.5)

57.8(32.3-94.9)

59.1(27.8-88.6)

Age at exit 1

61.9(21.1-102.4)

68.9(40.4-102.4)

67.7(40.4-102.4)

68.7(40.8-101.3)

69.8(40.5-98.3)

Years of follow-up 2

11.4(0.01-16.8)

11.5(0.01-16.7)

11.6(0.01-16.7)

11.6(0.02-16.6)

11.5(0.01-16.6)

Years until diagnosis 3

6.1(0.01-15.6)

6.0(0.01-15.3)

5.8(0.01-14.4)

6.0(0.02-14.7)

6.0(0.01-15.3)

BMI (kg/m 2 ) 1

24.02(10.2-77.9)

24.8(12.9-77.9)

21.1(12.9-22.5)

24.1(22.6-25-8)

28.8(25.9-77.9)

Hip circumference (cm)

100.0(50.0-179.0)

81.0(51.0-179.0)

71.0(52.0-117.0)

78.0(51.0-171.0)

90.0(52.0-179.0)

Waist circumference (cm)

78.0(50.0-179.0)

101.0(53.0-171.0)

93.0(57.0-115.0)

99.0(55.0-158.0)

107.5(53.0-171.0)

Premenopausal 4

35.5%(111560)

-

-

-

-

Peri/or of unknown menopausal status 4

18.7%(58887)

-

-

-

-

Postmenopausal 4

45.8%(144223)

-

-

-

-

Never HRT user 5

38.4%(120992)

54.7%(78,919)

45.0%(16569)

51.4%(25108)

63.6%(37242)

Past HRT user 5

7.0%(21980)

12.7%(18,278)

12.6%(4640)

13.1%(6401)

12.4%(7237)

Current HRT user 5

16.5%(51975)

29.6%(42,719)

39.8%(1462)

32.4%(15826)

20.9%(12266)

Missing HRT use 5

38.0%(119723)

3%(4,307)

2.6%(956)

3.1%(1511)

3.1%(1840)

  1. 1Median (range); 2reverse Kaplan Meier median (range); 3in primary incident cases only; 4percentage (number); 5excluding premenopausal women at baseline recruitment; 6in postmenopausal women at baseline recruitment only. BMI, body mass index; HRT, hormone replacement therapy.